Survey on Frailty and Sarcopenia in Rheumatoid Arthritis Patients

Survey on Frailty and Sarcopenia in Rheumatoid Arthritis Patients - Survey on Frailty and Sarcopenia in Rheumatoid Arthritis Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045119

Enrollment

100

Registered

2021-08-11

Start date

2020-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with rheumatoid arthritis who meet the 1987 criteria of ACR or the 2010 criteria of the ACR/EULAR and under the management of board certified rheumatologists. Additionally, patients are undergoing treatment and follow-up and meet all of the following conditions 1) Age 50 years or older at the date of consent 2) Written consent has been obtained from the subject himself/herself for participation in this study 3) Able to answer and fill in the self-administered survey form by themselves. 4) Patients who are receiving molecular targeted drugs, csDMARDs or GCs at the start of the study

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Frailty and sarcopenia	—

Countries

Japan

Contacts

Public ContactMasayo Kojima

National Center for Geriatrics and Gerontology masayok@ncgg.go.jp

masayok@ncgg.go.jp0562-46-2311

Outcome results